{
  "docId": "019de077-8566-7247-8a65-bb40d287c138",
  "docSlug": "3a5ef691e659aba2296672e3bbfa035c",
  "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides",
  "authorId": "an2-therapeutics",
  "authorName": "AN2 Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2025-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 36,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "traction",
  "function": "show_traction",
  "density": "balanced",
  "nDataPoints": 24,
  "notes": "The slide presents TEAE (Treatment-emergent adverse events) and SAE (Serious adverse events) data.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-8566-7247-8a65-bb40d287c138/14",
  "deckHref": "/decks/019de077-8566-7247-8a65-bb40d287c138",
  "deckJsonHref": "/decks/019de077-8566-7247-8a65-bb40d287c138.json",
  "deckAnchorHref": "/decks/019de077-8566-7247-8a65-bb40d287c138#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.555,
        "w": 0.333,
        "x": 0.644,
        "y": 0.232
      },
      "kind": "callout",
      "text": "Key insights: Low discontinuations, GI events mild, Hemoglobin effect consistent, No anemia SAEs, No study withdrawal, Safety profile supports development",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4372253d-7cf5-4ac0-8833-dd26377b1693",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.47,
        "x": 0.229,
        "y": 0.918
      },
      "kind": "disclaimer",
      "text": "TEAE: Treatment-emergent adverse events; SAE: Serious adverse events",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b254f764-57a1-4650-8bb9-f780492e47f6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.455,
        "w": 0.592,
        "x": 0.039,
        "y": 0.332
      },
      "kind": "table",
      "text": "TEAEs, EBO+OBR (N=39), Placebo+OBR (N=41), Mild, Moderate, Severe, Life threatening, Death, SAEs, Drug discontinuation due to TEAE",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a697a6f9-de0f-4f06-a538-f54b614c569c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.738,
        "x": 0.025,
        "y": 0.045
      },
      "kind": "title",
      "text": "EBO Appears Generally Well Tolerated in Phase 2 Trial",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f167d19d-2756-441a-b577-781bbbb895e1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "c9f24881-b5a0-4a8a-81e0-2ff7bb6e44dc",
      "evidence": "TEAEs, EBO+OBR (N=39), Placebo+OBR (N=41), Mild, Moderate, Severe, Life threatening, Death, SAEs, Drug discontinuation due to TEAE",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 14,
      "from": 9,
      "beatId": "97a1ede8-85ba-45c5-94c2-981cd0dfd720",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "The document presents clinical trial results and other traction metrics for AN2 Therapeutics' pipeline candidates.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}